Key result
Long non-coding RNAs actively regulate endothelial function and offer emerging therapeutic targets for cardiovascular disease.
Why the study?
Understanding molecular determinants governing endothelial function and dysfunction is essential to develop novel clinical breakthroughs, with emerging evidence showing long non-coding RNAs actively regulate endothelial transcriptome and function.
Long non-coding RNAs are emerging as key regulators of endothelial function and potential therapeutic targets in cardiovascular diseases.
Does not yet change clinical practice; leaves open lncRNA modulation as a therapeutic target in endothelial dysfunction.
Present throughout the vasculature, endothelial cells (ECs) are essential for blood vessel function and play a central role in the pathogenesis of diverse cardiovascular diseases. Understanding the intricate molecular determinants governing endothelial function and dysfunction is essential to develop novel clinical breakthroughs and improve knowledge. An increasing body of evidence demonstrates that long non-coding RNAs (lncRNAs) are active regulators of the endothelial transcriptome and function, providing emerging insights into core questions surrounding EC contributions to pathology, and perhaps the emergence of novel therapeutic opportunities. In this review, we discuss this class of non-coding transcripts and their role in endothelial biology during cardiovascular development, homeostasis, and disease, highlighting challenges during discovery and characterization and how these have been overcome to date. We further discuss the translational therapeutic implications and the challenges within the field, highlighting lncRNA that support endothelial phenotypes prevalent in cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Monteiro et al. (2019) conducted a review in Cardiovascular disease. Long non-coding RNAs (lncRNAs) was evaluated. Long non-coding RNAs act as active regulators of the endothelial transcriptome and function, offering emerging insights into cardiovascular disease pathology and potential therapeutic opportunities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: